Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$7.59
-0.19-2.44%
Last update: Aug 20, 10:22 AM
Entrada Therapeutics Inc
TRDANASDAQ
Entrada Therapeutics Market Sentiment
Market sentiment signals for Entrada Therapeutics (TRDA): analyst consensus, short interest, options flow and insider activity.
Key Signals
Analyst Consensus— Outperform
Short Interest▲ 8.5% short float
Options Flow▲ 0.00 P/C ratio
Insider Activity▼ Net Seller (30d)
Analyst Consensus
Outperform
5 analysts
Options Flow (P/C)
0.00
More calls — Bullish
5 calls · 0 puts
Avg Consensus PT
$23
+199.7%
Highest Price Target
$29
+282.1%
Roth MKM
Lowest Price Target
$17
+124.0%
Guggenheim
Short Interest
8.5%
Declining — Bullish
Insider Activity (30d)
Net Seller
Short Interest — % of Float
Recent Analyst Actions
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Jun 8, 2026 | Guggenheim | Debjit Chattopadhyay— | +124.0% | $20 → $17 | Maintained | Buy |
| May 8, 2026 | HC Wainwright & Co. | Raghuram Selvaraju— | — | — | Downgrade | Buy→Neutral |
